日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Discovery and Optimization of a Synthetic Class of Nectin-4-Targeted CD137 Agonists for Immuno-oncology

用于免疫肿瘤学的一类合成 Nectin-4 靶向 CD137 激动剂的发现和优化

Punit Upadhyaya, Julia Kristensson, Johanna Lahdenranta, Elizabeth Repash, Jun Ma, Jessica Kublin, Gemma E Mudd, Lia Luus, Phil Jeffrey, Kristen Hurov, Kevin McDonnell, Nicholas Keen

Anticancer immunity induced by a synthetic tumor-targeted CD137 agonist

合成的肿瘤靶向CD137激动剂诱导的抗癌免疫

Punit Upadhyaya #,Johanna Lahdenranta #,Kristen Hurov #,Sailaja Battula,Rachel Dods,Eric Haines,Marianna Kleyman,Julia Kristensson,Jessica Kublin,Rachid Lani,Jun Ma,Gemma Mudd,Elizabeth Repash,Katerine Van Rietschoten,Tom Stephen,Fanglei You,Helen Harrison,Liuhong Chen,Kevin McDonnell,Philip Brandish,Nicholas Keen

BT7480, a novel fully synthetic Bicycle tumor-targeted immune cell agonist™ (Bicycle TICA™) induces tumor localized CD137 agonism

BT7480 是一种新型全合成的 Bicycle 肿瘤靶向免疫细胞激动剂™ (Bicycle TICA™),可诱导肿瘤局部 CD137 激动作用。

Kristen Hurov # ,Johanna Lahdenranta # ,Punit Upadhyaya ,Eric Haines ,Heather Cohen ,Elizabeth Repash ,Drasti Kanakia ,Jun Ma ,Julia Kristensson ,Fanglei You ,Carly Campbell ,David Witty ,Mike Kelly ,Stephen Blakemore ,Phil Jeffrey ,Kevin McDonnell ,Philip Brandish ,Nicholas Keen